Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 321-330 of 730 results
Scientific Reports, 2019 • October 15, 2019
This study investigated the roles of activated microglia and infiltrating macrophages in neuropathic pain (NeP) associated with chronic progressive spinal cord compression using a mouse model. The mai...
KEY FINDING: The severity of spinal cord compression correlated with the proportion of activated microglia and hematogenous macrophages in the spinal cord.
eLife, 2019 • December 3, 2019
This study establishes a murine model of sepsis with ICU-like interventions to investigate chronic muscle weakness in survivors. The research demonstrates that sepsis survivors have prolonged muscle w...
KEY FINDING: Sepsis survivors exhibit chronic muscle weakness for at least one month, even after muscle mass recovery.
Top Spinal Cord Inj Rehabil, 2019 • January 1, 2019
This clinical review addresses the unique challenges in the surveillance, prevention, diagnosis, and management of catheter-associated urinary tract infections (CAUTI) in individuals with spinal cord ...
KEY FINDING: Surveillance of CAUTI is challenging in the SCI population because the ability to detect symptoms typically used to diagnose CAUTI, such as suprapubic pain and dysuria, is often impaired.
Journal of Neuroinflammation, 2019 • December 10, 2019
This study demonstrates that lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with SCI. The study shows that reducing α-synuclein pr...
KEY FINDING: Downregulation of α-synuclein reduces inflammatory infiltration and preserves myelin after SCI.
Spinal Cord, 2020 • February 18, 2020
This survey investigates the clinical algorithms relevant for SCI-AP and analyses the utility of the CDC-criteria for the diagnosis of SCI-AP and decision-making on its therapy. The accuracy in decisi...
KEY FINDING: Awareness of diagnostic CDC-criteria for pneumonia was confirmed by 88% of departments.
INTERNATIONAL JOURNAL OF MOlecular medicine, 2020 • January 31, 2020
The study aimed to evaluate the effect of the CX3CR1 inhibitor AZD8797 in early recovery after acute SCI and elucidate its potential mechanism in blocking inflammation and apoptosis. AZD8797 improved ...
KEY FINDING: CX3CR1 and CX3CL1 expression levels increase after spinal cord injury, peaking at 10 days, suggesting their involvement in the inflammatory response.
Journal of Neuroinflammation, 2020 • May 19, 2020
This review discusses the potential role of environmental factors, particularly nerve injury, in initiating and propagating ALS. Animal models demonstrate that nerve injury can accelerate disease prog...
KEY FINDING: Nerve injury can hasten functional decline and shorten survival in SOD1 rat models of ALS, suggesting injury can initiate earlier disease onset and promote local spread.
Cells, 2020 • June 8, 2020
This review discusses the neuropsychological abnormalities and pathophysiological alterations in the brain following SCI, including cognitive impairments and mood disturbances. Clinical evidence indic...
KEY FINDING: SCI patients are at a significantly higher risk for developing dementia, with some studies suggesting they are 13 times more likely to develop cognitive impairments.
eLife, 2020 • September 7, 2020
This study demonstrates evidence for a receptor-mediated signaling role for complement C1q in the CNS, modulating NSC migration, proliferation, and lineage commitment. The study defines and validates ...
KEY FINDING: C1q activates specific intracellular signaling pathways in NSC to modulate NSC behavior.
BMJ Open, 2020 • October 5, 2020
The RESCOM study is a prospective, international, multicentre cohort study designed to identify modifiable predictors of pneumonia in individuals with spinal cord injury (SCI) during inpatient rehabil...
KEY FINDING: The study aims to evaluate the ability of parameters of respiratory function to predict and understand variation in inpatient risk of pneumonia in SCI.